Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Protalix Biotherapeutics Inc (NYSE MKT LLC:PLX)

0.7879
Delayed Data
As of 3:59pm ET
 +0.0279 / +3.67%
Today’s Change
0.74
Today|||52-Week Range
2.35
-22.75%
Year-to-Date
No recent news for Protalix Biotherapeutics Inc.

Today’s Trading

Previous close0.76
Today’s open0.80
Day’s range0.75 - 0.82
Volume62,622
Average volume (3 months)451,866
Market cap$75.8M
Dividend yield--
Data as of 3:59pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)-6.67%
Earnings growth (this year)+256.25%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+31.68%
P/E ratioNM
Price/Sales11.27
Price/Book--

Competitors

 Today’s
change
Today’s
% change
AUPHAurinia Pharmaceutic...+0.02+0.89%
PTIEPain Therapeutics In...+0.02+1.13%
GNCAGenocea Biosciences ...+0.65+21.59%
TENXTenax Therapeutics I...+0.02+0.85%
Data as of 4:00pm ET, 02/12/2016

Financials

Next reporting dateMarch 10, 2016
EPS forecast (this quarter)$0.60
Annual revenue (last year)$15.2M
Annual profit (last year)-$29.9M
Net profit margin-197.51%

Profile

Sector
Health Services
Industry
Services to the Health Industry
President, Chief Executive Officer &
Director
Moshe Manor
Chief Operating Officer
Tzvi Palash
Corporate headquarters
Carmiel, Haifa

Forecasts

Partner Offers